Published online January 8, 2007
doi:10.1084/jem.20062056
The Journal of Experimental Medicine, Vol. 204, No. 1, 49-55
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Zhang et al.
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells
Bin Zhang1,
Natalie A. Bowerman3,
Joseph K. Salama2,
Hank Schmidt2,
Michael T. Spiotto1,
Andrea Schietinger1,
Ping Yu1,
Yang-Xin Fu1,
Ralph R. Weichselbaum2,
Donald A. Rowley1,
David M. Kranz3, and
Hans Schreiber1
1 Department of Pathology and Committee on Immunology and 2 Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637
3 Department of Biochemistry, University of Illinois, Urbana, IL 61801
CORRESPONDENCE Bin Zhang: bzhang2{at}uchicago.edu OR Hans Schreiber: hszz{at}uchicago.edu
Targeting cancer cells, as well as the nonmalignant stromal cells cross-presenting the tumor antigen (Ag), can lead to the complete destruction of well-established solid tumors by adoptively transferred Ag-specific cytotoxic T lymphocytes (CTLs). If, however, cancer cells express only low levels of the Ag, then stromal cells are not destroyed, and the tumor escapes as Ag loss variants. We show that treating well-established tumors expressing low levels of Ag with local irradiation or a chemotherapeutic drug causes sufficient release of Ag to sensitize stromal cells for destruction by CTLs. This was shown directly using high affinity T cell receptor tetramers for visualizing the transient appearance of tumor-specific peptideMHC complexes on stromal cells. Maximum loading of tumor stroma with cancer Ag occurred 2 d after treatment and coincided with the optimal time for T cell transfer. Under these conditions, tumor rejection was complete. These findings may set the stage for developing rational clinical protocols for combining irradiation or chemotherapy with CTL therapy.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Zhang, B., Zhang, Y., Bowerman, N. A., Schietinger, A., Fu, Y.-X., Kranz, D. M., Rowley, D. A., Schreiber, H.
(2008). Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma. Cancer Res.
68: 1563-1571
[Abstract]
[Full Text]
-
Shanker, A., Verdeil, G., Buferne, M., Inderberg-Suso, E.-M., Puthier, D., Joly, F., Nguyen, C., Leserman, L., Auphan-Anezin, N., Schmitt-Verhulst, A.-M.
(2007). CD8 T Cell Help for Innate Antitumor Immunity. J. Immunol.
179: 6651-6662
[Abstract]
[Full Text]
-
Gajewski, T. F.
(2007). Failure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor Microenvironment. Clin. Cancer Res.
13: 5256-5261
[Abstract]
[Full Text]
-
Paulos, C. M., Kaiser, A., Wrzesinski, C., Hinrichs, C. S., Cassard, L., Boni, A., Muranski, P., Sanchez-Perez, L., Palmer, D. C., Yu, Z., Antony, P. A., Gattinoni, L., Rosenberg, S. A., Restifo, N. P.
(2007). Toll-like Receptors in Tumor Immunotherapy. Clin. Cancer Res.
13: 5280-5289
[Abstract]
[Full Text]
-
Ko, H.-J., Kim, Y.-J., Kim, Y.-S., Chang, W.-S., Ko, S.-Y., Chang, S.-Y., Sakaguchi, S., Kang, C.-Y.
(2007). A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model. Cancer Res.
67: 7477-7486
[Abstract]
[Full Text]
-
Melero, I.
(2007). Antitumor T-cell wars: do CD4s outwit CD8s?. Blood
109: 5070-5071
[Full Text]
-
Zhang, B., Bowerman, N. A., Salama, J. K., Schmidt, H., Spiotto, M. T., Schietinger, A., Yu, P., Fu, Y.-X., Weichselbaum, R. R., Rowley, D. A., Kranz, D. M., Schreiber, H.
(2007). Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. J. Cell Biol.
176: i6-i6
[Full Text]